ITEMS IN AFP WITH KEYWORD:
What are the effects of treatments to prevent fractures in postmenopausal women?
The North American Menopause Society (NAMS) has released an updated position statement on the use of estrogen therapy (ET) and combined estrogen-progestogen therapy (EPT) in perimenopausal and postmenopausal women, based on the latest evidence on the risks and benefits associated with the use of ET and EPT.
Nov 1, 2006 Issue
Hormone Therapy in Postmenopausal and Perimenopausal Women [Cochrane for Clinicians]
Relatively healthy women taking combined continuous hormone therapy have higher risks of myocardial infarction and venous thromboembolism after one year, stroke after three years, and breast cancer after five years. In women who take hormone therapy continuously for five years, there is a lower inci...
Numerous reports in the medical literature and popular media have discussed the effectiveness of various nonhormonal agents in reducing menopausal hot flash symptoms. Data for these therapies are limited, and most of the studies have been conducted in women with a history of breast cancer. Selective...
Dec 15, 2005 Issue
Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women [Putting Prevention into Practice]
Case study: In keeping with the 2002 recommendation from the U.S. Preventive Services Task Force (USPSTF) that women 65 years of age and older should be screened for osteoporosis, you have ordered a dual-energy x-ray absorptiometry test for a 66-year-old white woman. The results indicate that she is at increased risk of osteoporotic fractures.
Aug 15, 2005 Issue
AHRQ Releases Evidence Report on Managing Menopause-Related Symptoms [Practice Guidelines]
The Agency for Healthcare Research and Quality (AHRQ) has released the results of a systematic review on managing menopause-related symptoms. The report evaluates the benefits and harms of common interventions to relieve menopause-related symptoms.
Jul 15, 2005 Issue
Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women [U.S. Preventive Services Task Force]
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on hormone therapy for the prevention of chronic conditions in post-menopausal women and the supporting scientific evidence and updates the Task Force’s 2002 recommendations on hormone replacement therapy.
The North American Menopause Society (NAMS) has released an evidence-based position statement on the treatment of vasomotor symptoms associated with menopause to provide recommendations on the most effective treatments.
The herb black cohosh, or Actaea racemosa (formerly named Cimicifuga racemosa), is native to North America. The roots and rhizomes of this herb are widely used in the treatment of menopausal symptoms and menstrual dysfunction. Studies have demonstrated that this botanic medicine, when standardized p...
Night sweats are a common outpatient complaint, yet literature on the subject is scarce. Tuberculosis and lymphoma are diseases in which night sweats are a dominant symptom, but these are infrequently found to be the cause of night sweats in modern practice. While these diseases remain important dia...